{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03228732",
            "orgStudyIdInfo": {
                "id": "HP-00075896"
            },
            "organization": {
                "fullName": "University of Maryland, Baltimore",
                "class": "OTHER"
            },
            "briefTitle": "The Effects of Fluoxetine and/or DHEA",
            "officialTitle": "The Effects of the Selective Serotonin Reuptake Inhibitor, Fluoxetine and/or DHEA, on Neuroendocrine, Autonomic Nervous System and Metabolic Counterregulatory Responses During Repeated Hypoglycemia in T1DM Individuals",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "the-effects-of-fluoxetine-and-or-dhea"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2017-12-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-02-15",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2017-07-20",
            "studyFirstSubmitQcDate": "2017-07-21",
            "studyFirstPostDateStruct": {
                "date": "2017-07-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-05",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Stephen N. Davis, MBBS",
                "investigatorTitle": "Chairman of Medicine",
                "investigatorAffiliation": "University of Maryland, Baltimore"
            },
            "leadSponsor": {
                "name": "University of Maryland, Baltimore",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "(1) To determine how the Selective Serotonin Reuptake Inhibitor (SSRI), fluoxetine (Prozac), an antidepressant often used to treat depression, stimulates the participant's body's ability to defend against low blood sugar (hypoglycemia). (2) To learn how a hormone, dehydroepiandrosterone (DHEA), stimulates the participant's body's ability to defend itself from low blood sugar (hypoglycemia). DHEA is a hormone produced naturally in the human body. However, it can be manufactured and is sold as an over-the-counter dietary supplement. The dose the investigators are giving in this study is higher than the usual recommended dosage taken as a supplement for certain medical conditions. (3) To study combined effects of fluoxetine and DHEA during low blood glucose. In the present study, the investigators will measure the participant's body's responses to hypoglycemia when given fluoxetine or DHEA or fluoxetine and DHEA or a placebo (a pill with no fluoxetine or DHEA). Approximately 64 individuals with type 1 diabetes will take part in this study."
        },
        "conditionsModule": {
            "conditions": [
                "Type 1 Diabetes Mellitus"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Participants will be randomized into 2 groups. Group 1 will consist of a random order of Protocol 1 and Protocol 5. Group 2 will consist of a randomized order of Protocols 2, 3, 4",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Placebo 1",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Visit 1:\n\nStudy Day 1: Hyperinsulinemia/ euglycemia clamp in the AM and PM. Study Day 2: Hyperinsulinemia/ hypoglycemia clamp in the AM only. 8-weeks of treatment with placebo\n\nVisit 2:\n\nsame as visit 1",
                    "interventionNames": [
                        "Drug: Placebo Oral Tablet"
                    ]
                },
                {
                    "label": "Placebo 2",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Visit 1:\n\nStudy Day 1: Hyperinsulinemia/ hypoglycemia clamp in the AM and PM. Study Day 2: Hyperinsulinemia/ hypoglycemia clamp in the AM only. 8-weeks of treatment with placebo\n\nVisit 2:\n\nsame as visit 1",
                    "interventionNames": [
                        "Drug: Placebo Oral Tablet"
                    ]
                },
                {
                    "label": "Fluoxetine",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Visit 1:\n\nStudy Day 1: Hyperinsulinemia/ hypoglycemia clamp in the AM and PM. Study Day 2: Hyperinsulinemia/ hypoglycemia clamp in the AM only. 8-weeks of treatment with fluoxetine\n\nVisit 2:\n\nsame as visit 1",
                    "interventionNames": [
                        "Drug: Fluoxetine"
                    ]
                },
                {
                    "label": "DHEA",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Visit 1:\n\nStudy Day 1: Hyperinsulinemia/ hypoglycemia clamp in the AM and PM. Study Day 2: Hyperinsulinemia/ hypoglycemia clamp in the AM only. 8-weeks of treatment with DHEA\n\nVisit 2:\n\nsame as visit 1",
                    "interventionNames": [
                        "Drug: DHEA"
                    ]
                },
                {
                    "label": "Fluoxetine and DHEA",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Visit 1:\n\nStudy Day 1: Hyperinsulinemia/ hypoglycemia clamp in the AM and PM. Study Day 2: Hyperinsulinemia/ hypoglycemia clamp in the AM only. 8-weeks of treatment with fluoxetine and DHEA\n\nVisit 2:\n\nsame as visit 1",
                    "interventionNames": [
                        "Drug: Fluoxetine and DHEA"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Placebo Oral Tablet",
                    "description": "There will be two 2-day inpatient visits with 8-weeks of treatment with placebo between those visits.",
                    "armGroupLabels": [
                        "Placebo 1"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo Oral Tablet",
                    "description": "There will be two 2-day inpatient visits with 8-weeks of treatment with placebo between those visits.",
                    "armGroupLabels": [
                        "Placebo 2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fluoxetine",
                    "description": "There will be two 2-day inpatient visits with 8-weeks of treatment with fluoxetine between those visits.",
                    "armGroupLabels": [
                        "Fluoxetine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "DHEA",
                    "description": "There will be two 2-day inpatient visits with 8-weeks of treatment with DHEA between those visits.",
                    "armGroupLabels": [
                        "DHEA"
                    ],
                    "otherNames": [
                        "dehydroepiandrosterone"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fluoxetine and DHEA",
                    "description": "There will be two 2-day inpatient visits with 8-weeks of treatment with fluoxetine and DHEA between those visits.",
                    "armGroupLabels": [
                        "Fluoxetine and DHEA"
                    ],
                    "otherNames": [
                        "Prozac, dehydroepiandrosterone"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in the level of catecholamines in plasma",
                    "timeFrame": "An average of 3 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* 64 (32 males, 32 females) T1DM patients aged 18-50 yr.\n* HbA1c \\< 11.0%\n* No clinically diagnosed diabetic tissue complications (i.e. history of retinopathy, neuropathy, stasis ulcers, etc)\n* Body mass index \\< 40kg \u00b7 m-2\n\nExclusion Criteria:\n\n* Pregnancy\n* Subjects unable to give voluntary informed consent\n* Subjects on anticoagulant drugs, anemic or with known bleeding diatheses\n* Subjects taking any of the following medications will be excluded: Non-selective Beta Blockers, Sedative-Hypnotics, Anticonvulsants, Antiparkinsonian drugs, Antipsychotics, Antidepressants, Mood stabilizers, CNS Stimulants, Opioids, Hallucinogens\n* Subjects with a recent medical illness or past history of severe depression, mania or psychotic disease\n* Subjects that score greater than 50 on the depression scale\n* Subjects unwillingness or inability to comply with approved contraception measures\n* Abnormal results following screening tests and physical examination that are clinically significant\n* Subjects with a history of severe uncontrolled hypertension (i.e., blood pressure greater than 160/100), heart disease, cerebrovascular incidents\n* Clinically significant cardiac abnormalities (e.g. heart failure, arrhythmias, ischemic tachycardia, S-T segment deviations, etc.) from history or from cardiac stress testing in subjects \u2265 40 years old.\n* Pneumonia\n* Hepatic Failure/Jaundice\n* Creatinine greater than 1.6 mg/dl\n* Acute Cerebrovascular/ Neurological deficit\n* Fever greater than 38 \u00b0C\n\nScreening Laboratory Tests Exclusion Criteria\n\n* Hematocrit lower than 32\n* WBC lower than 3 thou/ul or greater than 14 thou/ul\n* Liver Function Tests: SGOT and SGPT greater than twice upper limit of normal range (i.e. greater than 80 U/L).\n* TBil greater than 2 mg/dl\n* Alkaline Phosphatase greater than 150U/L\n* Positive HIV, Hep B, Hep C\n* Hepatic transaminase \\> 2x normal",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "50 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Maka Siamashvili, MD",
                    "role": "CONTACT",
                    "phone": "410-706-5623",
                    "email": "msiamashvili@som.umaryland.edu"
                },
                {
                    "name": "Vanessa Briscoe, PhD",
                    "role": "CONTACT",
                    "email": "vbriscoe@som.umaryland.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Stephen N Davis, MBBS",
                    "affiliation": "University of Maryland, Baltimore",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Maryland",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Maka Siamashvili, MD",
                            "role": "CONTACT",
                            "phone": "410-706-5623",
                            "email": "msiamashvili@som.umaryland.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003922",
                    "term": "Diabetes Mellitus, Type 1"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7117",
                    "name": "Diabetes Mellitus, Type 1",
                    "asFound": "Type 1 Diabetes Mellitus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M10053",
                    "name": "Hypoglycemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005473",
                    "term": "Fluoxetine"
                },
                {
                    "id": "D000003687",
                    "term": "Dehydroepiandrosterone"
                }
            ],
            "ancestors": [
                {
                    "id": "D000017367",
                    "term": "Selective Serotonin Reuptake Inhibitors"
                },
                {
                    "id": "D000014179",
                    "term": "Neurotransmitter Uptake Inhibitors"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000018490",
                    "term": "Serotonin Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018687",
                    "term": "Antidepressive Agents, Second-Generation"
                },
                {
                    "id": "D000000928",
                    "term": "Antidepressive Agents"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                },
                {
                    "id": "D000065690",
                    "term": "Cytochrome P-450 CYP2D6 Inhibitors"
                },
                {
                    "id": "D000065607",
                    "term": "Cytochrome P-450 Enzyme Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000000276",
                    "term": "Adjuvants, Immunologic"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M8601",
                    "name": "Fluoxetine",
                    "asFound": "Fetal",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15512",
                    "name": "Serotonin",
                    "relevance": "LOW"
                },
                {
                    "id": "M19649",
                    "name": "Selective Serotonin Reuptake Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M6888",
                    "name": "Dehydroepiandrosterone",
                    "asFound": "Larger",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4247",
                    "name": "Antidepressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M30537",
                    "name": "Cytochrome P-450 Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M3628",
                    "name": "Adjuvants, Immunologic",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "T386",
                    "name": "DHEA (Dehydroepiandrosterone)",
                    "asFound": "Larger",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Ot",
                    "name": "Other Dietary Supplements"
                }
            ]
        }
    },
    "hasResults": false
}